ISBAGIO, H. Use of anti-citrullinated peptide (Anti–CCP) antibodies in distinguishing patients with systemic lupus erythematosus and rheumatoid arthritis. Medical Journal of Indonesia, v. 13, n. 4, p. 227-31, 1 Nov. 2004.